Literature DB >> 26698024

Glucocorticoids in 2015: New answers to old problems.

Sarah A Jones1, Eric F Morand1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26698024     DOI： 10.1038/nrrheum.2015.176

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  10 in total

1.  Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus.

Authors:  Ioana Ruiz-Arruza; Amaia Ugarte; Ivan Cabezas-Rodriguez; Jose-Alejandro Medina; Miguel-Angel Moran; Guillermo Ruiz-Irastorza
Journal:  Rheumatology (Oxford)       Date:  2014-03-27       Impact factor: 7.580

2.  Lack of glucocorticoid-induced leucine zipper (GILZ) deregulates B-cell survival and results in B-cell lymphocytosis in mice.

Authors:  Stefano Bruscoli; Michele Biagioli; Daniele Sorcini; Tiziana Frammartino; Monica Cimino; Paolo Sportoletti; Emanuela Mazzon; Oxana Bereshchenko; Carlo Riccardi
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

Review 3.  Diamonds are forever: the cortisone legacy.

Authors:  Stephen G Hillier
Journal:  J Endocrinol       Date:  2007-10       Impact factor: 4.286

4.  Therapeutic potential of targeting IL-17.

Authors:  Sarah A Jones; Caroline E Sutton; Daniel Cua; Kingston H G Mills
Journal:  Nat Immunol       Date:  2012-11       Impact factor: 25.606

5.  GILZ regulates Th17 responses and restrains IL-17-mediated skin inflammation.

Authors:  Sarah A Jones; Diluptha N Perera; Huapeng Fan; Brendan E Russ; James Harris; Eric F Morand
Journal:  J Autoimmun       Date:  2015-06-13       Impact factor: 7.094

Review 6.  Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis.

Authors:  Elaine Beaulieu; Eric F Morand
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

7.  Glucocorticoid Use in Patients With Systemic Lupus Erythematosus: Association Between Dose and Health Care Utilization and Costs.

Authors:  Shih-Yin Chen; Chan-Bum Choi; Qian Li; Wei-Shi Yeh; Yuan-Chi Lee; Amy H Kao; Matthew H Liang
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-08       Impact factor: 4.794

8.  Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.

Authors:  Lauren P Schewitz-Bowers; Philippa J P Lait; David A Copland; Ping Chen; Wenting Wu; Ashwin D Dhanda; Barbara P Vistica; Emily L Williams; Baoying Liu; Shayma Jawad; Zhiyu Li; William Tucker; Sima Hirani; Yoshiyuki Wakabayashi; Jun Zhu; Nida Sen; Becky L Conway-Campbell; Igal Gery; Andrew D Dick; Lai Wei; Robert B Nussenblatt; Richard W J Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

9.  Glucocorticoid-induced leucine zipper (GILZ) inhibits B cell activation in systemic lupus erythematosus.

Authors:  Sarah A Jones; Andrew E J Toh; Dragana Odobasic; Marie-Anne Virginie Oudin; Qiang Cheng; Jacinta P W Lee; Stefan J White; Brendan E Russ; Simona Infantino; Amanda Light; David M Tarlinton; James Harris; Eric F Morand
Journal:  Ann Rheum Dis       Date:  2015-11-26       Impact factor: 19.103

10.  Prednisone, lupus activity, and permanent organ damage.

Authors:  Mae Thamer; Miguel A Hernán; Yi Zhang; Dennis Cotter; Michelle Petri
Journal:  J Rheumatol       Date:  2009-02-04       Impact factor: 4.666
  10 in total
  3 in total

1.  Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.

Authors:  Ana Tiganescu; Melanie Hupe; Yoshikazu Uchida; Theadora Mauro; Peter M Elias; Walter M Holleran
Journal:  Endocrinology       Date:  2018-01-01       Impact factor: 4.736

Review 2.  Obesity as a risk factor for malignant melanoma and non-melanoma skin cancer.

Authors:  K Karimi; T H Lindgren; C A Koch; Robert T Brodell
Journal:  Rev Endocr Metab Disord       Date:  2016-09       Impact factor: 6.514

3.  Divergent effects of acute versus chronic glucocorticoids in COVID-19.

Authors:  Philip C Robinson; Eric Morand
Journal:  Lancet Rheumatol       Date:  2021-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.